Pierre Louis Beaulieu

This inventor holds 45 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 6 EPO patents, primarily in Viral Inhibitors. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim (Canada) Ltd., Bio-mega/boehringer Ingelheim Research Inc.. Active years: 1996-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pierre Louis Beaulieu. Retrieved from https://idiyas.com/inventor/pierre-louis-beaulieu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 45 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 5.3

ph-index = 14

Forward Citations = 540(Granted Patents)

Location History:

Montr eal, CA (1996 - 2001)
Rosemeré, CA (2007)
Rosemére, CA (2007 - 2011)
Laval, CA (2005 - 2012)
Rosem ere, CA (1996 - 2016)
Rosemère, CA (2002 - 2016)

Company Filing History:

20 out of 1,562

Boehringer Ingelheim International Gmbh

patents

12 out of 62

Boehringer Ingelheim (Canada) Ltd.

patents

8 out of 18

Bio-mega/boehringer Ingelheim Research Inc.

patents

4. 3 out of 278

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

5. 1 out of 1

Bio-mega/boehringer Ingeleheim Research Inc.

patent

6. 1 out of 306

Boehringer Ingelheim Gmbh

patents

Years Active: 1996-2016

Loading Chart...

Areas of Expertise:

Cytomegalovirus

HIV Replication

Viral Polymerase

Inhibitors

Peptide Derivatives

Antiherpes

Src Family

Binding Assay

Protease Inhibitors

Tetrapeptide

Amino Acid Side Chain

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9505775 - Inhibitors of cytomegalovirus (2016-11-29),

2. 9399645 - Inhibitors of HIV replication (2016-07-26),

3. 9315499 - Cytomegalovirus inhibitor compounds (2016-04-19),

4. 9249158 - Cytomegalovirus inhibitor compounds (2016-02-02),

5. 8912182 - Viral polymerase inhibitors (2014-12-16),

6. 8541402 - Viral polymerase inhibitors (2013-09-24),

7. 8476257 - Viral polymerase inhibitors (2013-07-02),

8. 8242140 - Viral polymerase inhibitors (2012-08-14),

9. 8030309 - Viral polymerase inhibitors (2011-10-04),

10. 7897622 - Viral polymerase inhibitors (2011-03-01),

11. 7893084 - Viral polymerase inhibitors (2011-02-22),

12. 7888363 - Viral polymerase inhibitors (2011-02-15),

13. 7879851 - Viral polymerase inhibitors (2011-02-01),

14. 7838537 - Viral polymerase inhibitors (2010-11-23),

15. 7803944 - Viral polymerase inhibitors (2010-09-28),

Title: The Innovative Journey of Pierre Louis Beaulieu

Introduction: Pierre Louis Beaulieu is a renowned inventor hailing from Rosemere, Canada. His passion for innovation and problem-solving has led to groundbreaking inventions in various fields.

Latest Patents: Pierre Louis Beaulieu holds several patents in the fields of renewable energy, sustainable agriculture, and medical devices. His most recent patent is a revolutionary solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the innovation industry, Pierre Louis Beaulieu has worked with top research institutions and universities to bring his ideas to life. He has been recognized with multiple awards for his contributions to the field of technology.

Collaborations: Throughout his career, Pierre Louis Beaulieu has collaborated with leading companies in Canada and beyond to develop cutting-edge solutions. His partnerships with industry experts have resulted in the successful commercialization of several inventions.

Conclusion: Pierre Louis Beaulieu's dedication to pushing the boundaries of innovation continues to inspire the next generation of inventors. His impact on various industries is a testament to his creativity and ingenuity.

Profile summary based on public USPTO records.